SynthesisEndocrine2020

Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonist dulaglutide in patients with type 2 diabetes: a systematic review and meta-analysis of 21 randomized controlled trials.

Suhui Qie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.